Omnipod 5 outcomes comparing Dexcom G6 and Freestyle Libre 2 plus users in adults with type 1 diabetes.
作者信息
Stimson Roland H, Dover Anna R, Lyall Marcus J, Kyle Catriona J, Wright Rohana J, McRobert Gayle, Strachan Mark W J, Gibb Fraser W
机构信息
Edinburgh Centre for Endocrinology and Diabetes, Edinburgh, United Kingdom of Great Britain and Northern Ireland.
出版信息
Diabet Med. 2025 Mar;42(3):e15465. doi: 10.1111/dme.15465. Epub 2024 Nov 4.
Abstract
摘要
相似文献
1
Omnipod 5 outcomes comparing Dexcom G6 and Freestyle Libre 2 plus users in adults with type 1 diabetes.
Diabet Med. 2025 Mar;42(3):e15465. doi: 10.1111/dme.15465. Epub 2024 Nov 4.
2
Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease.
World J Clin Cases. 2022 Aug 6;10(22):7794-7807. doi: 10.12998/wjcc.v10.i22.7794.
3
The Accuracy of Continuous Glucose Sensors in People with Diabetes Undergoing Hemodialysis (ALPHA Study).
Diabetes Technol Ther. 2023 Jul;25(7):447-456. doi: 10.1089/dia.2023.0013.
4
Feasibility of intraoperative continuous glucose monitoring: An observational study in general surgery patients.
J Clin Anesth. 2023 Aug;87:111090. doi: 10.1016/j.jclinane.2023.111090. Epub 2023 Mar 11.
5
Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age.
Diabetes Technol Ther. 2020 Mar;22(3):203-207. doi: 10.1089/dia.2019.0262. Epub 2020 Jan 23.
6
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium.
Diabetologia. 2024 Apr;67(4):650-662. doi: 10.1007/s00125-023-06084-2. Epub 2024 Jan 18.
7
The Dexcom glucose monitoring system-An isobornyl acrylate-free alternative for diabetic patients.
Contact Dermatitis. 2019 Jul;81(1):32-36. doi: 10.1111/cod.13248. Epub 2019 Mar 29.
8
Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
Acta Diabetol. 2021 Feb;58(2):231-237. doi: 10.1007/s00592-020-01614-5. Epub 2020 Oct 16.
9
Differences Between Glycated Hemoglobin and Glucose Management Indicator in Real-Time and Intermittent Scanning Continuous Glucose Monitoring in Adults With Type 1 Diabetes.
J Diabetes Sci Technol. 2024 Jul 29:19322968241262106. doi: 10.1177/19322968241262106.
10
Differences in glucose readings between the continuous glucose monitoring calibration free interstitial sensors versus capillary blood glucose monitoring by glucometer: An analysis of two cases.
Metabol Open. 2024 Apr 18;22:100282. doi: 10.1016/j.metop.2024.100282. eCollection 2024 Jun.
本文引用的文献
1
Outcomes after 1 year in adults using Omnipod 5: Real-world data from a UK diabetes centre.
Diabet Med. 2024 Dec;41(12):e15453. doi: 10.1111/dme.15453. Epub 2024 Oct 11.
2
Real-world data from first UK Omnipod 5 users: A single-centre observational study.
Diabetes Obes Metab. 2024 Aug;26(8):3462-3465. doi: 10.1111/dom.15629. Epub 2024 May 2.
3
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.
Diabetes Care. 2021 Jul;44(7):1630-1640. doi: 10.2337/dc21-0172. Epub 2021 Jun 7.
Zotero 插件